Pioglitazone 15mg + Metformin 500mg Tablets

Pioglitazone 15mg + Metformin 500mg ER combines pioglitazone with extended-release metformin for adults with type 2 diabetes for both medicines. Pioglitazone improves insulin sensitivity, while metformin reduces hepatic glucose production and improves insulin use. This combination is not for type 1 diabetes or diabetic ketoacidosis.
Take Pioglitazone 15mg + Metformin 500mg ER as prescribed, usually with food. Swallow extended-release tablets whole if applicable. Kidney function, glucose response, swelling, and gastrointestinal tolerance should be reviewed.
Pioglitazone improves insulin sensitivity through PPAR-gamma activation. Metformin lowers hepatic glucose production and improves insulin-mediated glucose use.
Possible effects include nausea, diarrhea, abdominal discomfort, metallic taste, weight gain, swelling, headache, and low blood sugar with insulin or sulfonylureas. Serious concerns include lactic acidosis, heart failure, liver injury, severe dehydration, macular edema, and allergic reaction.
Review kidney function, eGFR, heart failure, edema, liver disease, alcohol use, dehydration, iodinated contrast imaging, surgery, bladder-cancer history, pregnancy, breastfeeding, insulin, sulfonylureas, gemfibrozil, and rifampicin.
Type 2 diabetes mellitus in adults when a pioglitazone plus metformin extended-release combination is prescribed.
Targets insulin resistance and excess liver glucose production in one tablet, supporting glucose control in type 2 diabetes.
Pioglitazone 15mg + Metformin 500mg ER is used for type 2 diabetes to improve blood-sugar control with two complementary actions.
Metformin safety depends on kidney function, and impaired kidney function can increase lactic-acidosis risk.
Pioglitazone can cause fluid retention, which can worsen or trigger heart failure.
Extended-release tablets are usually swallowed whole unless the prescriber or label says otherwise.
Severe dehydration, slow breathing, unusual muscle pain, extreme weakness, rapid weight gain, breathlessness, or jaundice need urgent review.
Pioglitazone metformin ER, Type 2 diabetes combination, Insulin sensitizer metformin, Lactic acidosis warning, Edema heart failure warning, Kidney function eGFR, AR: Pioglitazone + Metformin ER أقراص, FR: Pioglitazone + Metformin ER comprimé, PT: Pioglitazone + Metformin ER comprimido, ES: Pioglitazone + Metformin ER tableta, RU: Pioglitazone + Metformin ER таблетки, ID: Pioglitazone + Metformin ER, VI: Pioglitazone + Metformin ER viên nén, MS: Pioglitazone + Metformin ER, TL: Pioglitazone + Metformin ER tableta, ZH-SG: Pioglitazone + Metformin ER 片剂
International B2B Enquiry
Send a structured B2B enquiry for Pioglitazone 15mg + Metformin 500mg Tablets under Diabetes Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Pioglitazone 15mg + Metformin 500mg Tablets